Stock FAQs

pdli stock price

by Madison Runolfsson Published 3 years ago Updated 2 years ago
image

Key Turning Points
52-Week High3.86
Fibonacci 50%2.97
Fibonacci 38.2%2.77
Last Price2.47
52-Week Low2.09
1 more row
Dec 30, 2020

Is PDL BioPharma (pdli) stock a good buy?

The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada. Is PDLI A Good Stock To Buy Now? There is not enough analysis data for PDL BioPharma. PDL BioPharma has received 221 “outperform” votes.

How does pdli's growth compare to other US stocks?

As for revenue growth, note that PDLI's revenue has grown -61.69% over the past 12 months; that beats the revenue growth of merely 3.43% of US companies in our set. Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for PDLI comes in at 64.79% -- higher than that of 95.9% of stocks in our set.

What is PDL BioPharma's PE (PDL) ratio compared to its peers?

Only 13.49% of the stock of PDL BioPharma is held by institutions. The P/E ratio of PDL BioPharma is -2.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

What is the price of PIMCO PDI stock?

Since then, PDI stock has decreased by 6.4% and is now trading at $25.44. View which stocks have been most impacted by COVID-19. How often does PIMCO Dynamic Income Fund pay dividends?

See more

image

How were PDL BioPharma's earnings last quarter?

PDL BioPharma, Inc. (NASDAQ:PDLI) posted its quarterly earnings results on Thursday, August, 6th. The biotechnology company reported ($0.43) EPS fo...

Who are PDL BioPharma's key executives?

PDL BioPharma's management team includes the following people: Mr. Dominique P. Monnet , CEO, Pres & Director (Age 59, Pay $1.2M) Mr. Edward A....

Who are some of PDL BioPharma's key competitors?

Some companies that are related to PDL BioPharma include Amgen (AMGN) , Gilead Sciences (GILD) , Vertex Pharmaceuticals (VRTX) , Regeneron Phar...

What other stocks do shareholders of PDL BioPharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PDL BioPharma investors own include AT&T (T) , OPKO Healt...

What is PDL BioPharma's stock symbol?

PDL BioPharma trades on the NASDAQ under the ticker symbol "PDLI."

What is PDL BioPharma's stock price today?

One share of PDLI stock can currently be purchased for approximately $2.47.

How much money does PDL BioPharma make?

PDL BioPharma (NASDAQ:PDLI) has a market capitalization of $282.86 million and generates $54.76 million in revenue each year.

How many employees does PDL BioPharma have?

PDL BioPharma employs 109 workers across the globe.

What is PDL BioPharma's official website?

The official website for PDL BioPharma is www.pdl.com .

What is PDL BioPharma's stock price today?

One share of PDLI stock can currently be purchased for approximately $2.47.

Where are PDL BioPharma's headquarters?

PDL BioPharma is headquartered at 932 SOUTHWOOD BLVD, INCLINE VILLAGE NV, 89 451.

What is MarketBeat community ratings?

MarketBeat's community ratings are surveys of what our community members think about PDL BioPharma and other stocks. Vote “Outperform” if you believe PDLI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PDLI will underperform the S&P 500 over the long term. You may vote once every thirty days.

What is the P/E ratio of PDL Biopharma?

The P/E ratio of PDL BioPharma is -2.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

When will PDL Biopharma release its earnings?

PDL BioPharma is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021. View our earnings forecast for PDL BioPharma.

What is PDL Biopharma?

PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.

Does PDL Biopharma pay dividends?

PDL BioPharma does not currently pay a dividend.

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Average short term outlook on maintaining the current direction.

Business Summary

Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital...

Component Grades

We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.

PDLI Stock Summary

With a year-over-year growth in debt of -89.49%, Pdl Biopharma Inc's debt growth rate surpasses merely 2.05% of about US stocks.

PDL BioPharma, Inc. (PDLI) Company Bio

PDL BioPharma Inc. manages a portfolio of patents and royalty assets related to the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. The company was founded in 1986 and is based in Incline Village, Nevada.

What happens if you sell royalty rights?

If we sell our income generating assets, such as our royalty rights, we anticipate all future distributions will be made in cash. If we do not sell our remaining income generating assets, they (and other remaining assets, if any) may be placed in a liquidating trust whereby the PDL stockholders of record as of the Final Record Date would receive a beneficial interest in the liquidating trust. Although receipt of a beneficial interest in a liquidating trust would technically not be in the form of cash, any future distributions to the beneficial interest holders in the trust would be expected to be in the form of cash, although property dispositions are possible.

What is PDL's safe harbor procedure?

Before distributions are made to PDL’s stockholders, PDL will follow the procedures found in the Plan of Dissolution and Sections 280 and 281 (a) of the Delaware General Corporate Law (DGCL) (the “Safe Harbor Procedures”) that, in summary, provide that the Company may give notice of PDL’s dissolution to potential claimants, accept or reject claims received, and offer a security for payment of contingent or unmatured contractual claims. Generally, the Safe Harbor Procedures reduce the potential liability of the Company’s stockholders and directors from future claims related to distributions made in liquidation. Under the Safe Harbor Procedures, after giving notice to holders of current, contingent and likely unknown claims and otherwise complying with the Safe Harbor Procedures to resolve those claims, PDL will petition the Delaware Court of Chancery to determine the amount and form of security that will be reasonably likely to be sufficient to pay known pending claims, contingent or unmatured contract claims, and unknown claims that are likely to arise based on facts known to PDL pursuant to the time periods and parameters set forth in the Plan of Dissolution and the DGCL. Upon completion of these steps and paying or making provision to pay claims described in the Plan of Dissolution, PDL will distribute its remaining assets to its stockholders. PDL does not anticipate making any distributions to stockholders before the Safe Harbor Procedures are completed, which are expected to take 12 – 18 months.

How long does a PDL last?

PDL will continue its existence for three years after filing the Certificate of Dissolution, or such longer period as the Delaware Court of Chancery may direct, for the purpose of prosecuting and defending suits, settling and closing its business, disposing of and conveying its property, discharging its liabilities and distributing to its stockholders any remaining assets.

When did PDL dissolve?

Following a resolution by PDL’s Board at its November 5, 2020 meeting, PDL filed the Certificate of Dissolution on January 4, 2021. Please refer to the Plan of Dissolution in PDL’s Proxy Statement for a detailed discussion of dissolution, but note the following:

When did PDL issue its proxy statement?

In July 2020 , PDL issued its proxy statement that requested approval by its stockholders of a Plan of Dissolution as the most efficient manner of winding up the Company’s business, paying and making provision to pay its creditors, and distributing the proceeds of its liquidation process to its stockholders pursuant to the Plan of Dissolution.

When did PDL file for dissolution?

At PDL’s 2020 Annual Meeting of Stockholders on August 19, 2020 , PDL’s stockholders approved the Plan of Dissolution and authorized the PDL Board of Directors (“the Board”) to direct the officers of the Company to file a certificate of dissolution with the State of Delaware (the “Certificate of Dissolution”) upon the Board’s determination that such a filing was in the best interests of PDL’s stockholders.

When will PDL disband in 2021?

We have not yet determined the timing or amount of future distributions, which will be determined by our Board of Directors and depend on our progress through the Safe Harbor Procedures in Delaware, the state in which PDL is incorporated and where it filed its certificate of dissolution on January 4, 2021.

What is the target price of ILPT?

ILPT: Raising target price to $34.00 INDUSTRIAL LOGISTICS PROPERT has an Investment Rating of BUY; a target price of $34.000000; an Industry Subrating of Medium; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Medium.

When will PIMCO distributions be payable?

The distributions are payable on December 1, 2021 to shareholders of record on November 12, 2021, with an ex-dividend date of November 10, 2021. Monthly Distribution Per ShareFundNYSE SymbolAmountChange FromPreviousMonthPercentageChange FromPreviousMo

What is an ex dividend date?

The Significance Of Ex-Dividend Dates An ex-dividend date signals when a company's shares cease to trade with its current dividend payout. There is a small intermission period before the company announces a new dividend. Usually, a company's ex-dividend date falls one business day before its record date.

What is MarketBeat community ratings?

MarketBeat's community ratings are surveys of what our community members think about PIMCO Dynamic Income Fund and other stocks. Vote “Outperform” if you believe PDI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PDI will underperform the S&P 500 over the long term. You may vote once every thirty days.

What is a PIMCO fund?

PIMCO Dynamic Income Fund is a non-diversified, closed-end management investment company. Its seeks current income as a primary objective and capital appreciation as a secondary objective. The company was founded on January 19, 2011 and is headquartered in New York, NY.

What is the official website of PIMCO?

The official website for PIMCO Dynamic Income Fund is us.allianzgi.com.

Where does PIMCO trade?

PIMCO Dynamic Income Fund trades on the New York Stock Exchange (NYSE) under the ticker symbol "PDI."

Does PIMCO Dynamic Income Fund have a long track record of dividend growth?

PIMCO Dynamic Income Fund does not have a long track record of dividend growth.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9